A Study of DZD8586 Combination in CLL/SLL (TAI-SHAN10)

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

December 31, 2029

Study Completion Date

January 31, 2030

Conditions

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Interventions

DRUG

DZD8586

DZD8586 will be taken orally once daily on days 1-28 of each cycle.

DRUG

Venetoclax

Venetoclax will be taken orally once daily on days 1-28 starting from cycle 4 day 1.